Handke, N.A.; Rupp, A.B.A.; Trimpop, N.; von Pawel, J.; Holdenrieder, S.
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients. Diagnostics 2021, 11, 356.
https://doi.org/10.3390/diagnostics11020356
AMA Style
Handke NA, Rupp ABA, Trimpop N, von Pawel J, Holdenrieder S.
Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients. Diagnostics. 2021; 11(2):356.
https://doi.org/10.3390/diagnostics11020356
Chicago/Turabian Style
Handke, Nikolaus A., Alexander B. A. Rupp, Nicolai Trimpop, Joachim von Pawel, and Stefan Holdenrieder.
2021. "Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients" Diagnostics 11, no. 2: 356.
https://doi.org/10.3390/diagnostics11020356
APA Style
Handke, N. A., Rupp, A. B. A., Trimpop, N., von Pawel, J., & Holdenrieder, S.
(2021). Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients. Diagnostics, 11(2), 356.
https://doi.org/10.3390/diagnostics11020356